Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Dimopoulos

Showing results (71-80 of 288) with videos related to

Pageof 29
Sort By:
Journal D'Urologie|January 1, 1983
[Genetic markers in papillary cancer of the bladder]M A Dimopoulos, A Germenis, P Savides, et al.
Immunotherapy|September 15, 2011
An overview of the VISTA trial: newly diagnosed, untreated patients with multiple myeloma ineligible for stem cell transplantationIvan Spicka, M V Mateos, K Redman, et al.
Human Pathology|March 7, 1998
The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlatesL Nakopoulou, C Vourlakou, A Zervas, et al.
Urology|June 28, 2000
Cushing syndrome as the presenting feature of metastatic Leydig cell tumor of the testisC Papadimitris, M Alevizaki, D Pantazopoulos, et al.
European Urology|January 1, 1984
Genetic markers in carcinoma of the prostateM A Dimopoulos, A Germenis, P Savides, et al.
Leukemia & Lymphoma|March 14, 1998
Very late relapse of Hodgkin's disease after 24 years of complete remissionM A Dimopoulos, E Kostis, A Anagnostopoulos, et al.
Presse Medicale (Paris, France : 1983)|March 19, 1983
[Genetic markers in benign hypertrophy of the prostate]A Germenis, P Savides, M A Dimopoulos, et al.
Gynecologic Oncology|March 1, 1997
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapyM A Dimopoulos, D Daliani, W Pugh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Molecular aspects of multiple myelomaN G Kastrinakis, V G Gorgoulis, P G Foukas, et al.
Radiology|November 1, 1994
Multiple myeloma: MR patterns of response to treatmentL A Moulopoulos, M A Dimopoulos, R Alexanian, et al.
Pageof 29

Showing results (71-80 of 288) with videos related to

Sort By:
Pageof 29
Journal D'Urologie|January 1, 1983
[Genetic markers in papillary cancer of the bladder]M A Dimopoulos, A Germenis, P Savides, et al.
Immunotherapy|September 15, 2011
An overview of the VISTA trial: newly diagnosed, untreated patients with multiple myeloma ineligible for stem cell transplantationIvan Spicka, M V Mateos, K Redman, et al.
Human Pathology|March 7, 1998
The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlatesL Nakopoulou, C Vourlakou, A Zervas, et al.
Urology|June 28, 2000
Cushing syndrome as the presenting feature of metastatic Leydig cell tumor of the testisC Papadimitris, M Alevizaki, D Pantazopoulos, et al.
European Urology|January 1, 1984
Genetic markers in carcinoma of the prostateM A Dimopoulos, A Germenis, P Savides, et al.
Leukemia & Lymphoma|March 14, 1998
Very late relapse of Hodgkin's disease after 24 years of complete remissionM A Dimopoulos, E Kostis, A Anagnostopoulos, et al.
Presse Medicale (Paris, France : 1983)|March 19, 1983
[Genetic markers in benign hypertrophy of the prostate]A Germenis, P Savides, M A Dimopoulos, et al.
Gynecologic Oncology|March 1, 1997
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapyM A Dimopoulos, D Daliani, W Pugh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Molecular aspects of multiple myelomaN G Kastrinakis, V G Gorgoulis, P G Foukas, et al.
Radiology|November 1, 1994
Multiple myeloma: MR patterns of response to treatmentL A Moulopoulos, M A Dimopoulos, R Alexanian, et al.
Pageof 29